Milestones

2017

Mr. Max Chan appointed as the VP of Finance and the Company Spokesperson
Ms. Joanna Meng retires as Chief Operating Officer. OBI Pharma appoints Mr. Max Chan as the new Chief Operating Officer.

2016

Received Grade A for TIPS Management.

2015

Received Gold Award at the BioTaipei.

2014

OBI-822 received the 11th Taiwan National Innovation Award
Received the “Best Investment Award” at the Venture Capital Star event hosted by Venture Capital Association.

2013

Established OBI PHARMA USA, INC
Appointed Amy Huang as the General Manager
Established OBI PHARMA (SHANGHAI) LIMITED.

2012

Established full subsidiary OBI PHARMA LIMITED in Hong Kong
Approved as a public company by the Security and Futures Bureau of Financial Supervisory Commission R.O.C.
Appointed Amy Huang as Chief Operating Officer, and Dr. Tony Yu as Chief Scientific Officer.

2011

Received Gold Award of the Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence.

2010

Officially registered as a biotechnology company with Taiwan’s Ministry of Economic Affairs.

2009

Dr. Youe-Kong Shue appointed as the CEO.

2002

OBI founded as a subsidiary of Optimer Pharmaceuticals with Dr. Michael Chang as the chairman.